Blood and genetic tests to accurately identify biomarkers of the disease are becoming available, but most diagnoses require a spinal tap or expensive PET scan. Not all patients are likely to benefit equally from anti-amyloid treatments.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/RFCGMOp
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment